Keytruda

Merck

Pharma

Merck touts Keytruda front-line win in endometrial cancer subtype

The news follows Merck's recent positive endometrial cancer readout from the first global phase 3 trial of its Kelun-Biotech-partnered sac-TMT.

Angus Liu Jul 15, 2026 3:33pm

Kelun

Kelun's sac-TMT win offers blueprint for Merck's global gap

Jul 15, 2026 10:20am

checkered flag finish line racecar

FDA expands Padcev-Keytruda combo to more MIBC patients

Jul 10, 2026 1:10pm

Gilead

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm

Person throwing piece of paper into full waste bin

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am

Merck

Merck's Welireg expands in kidney cancer with adjuvant nod

Jun 15, 2026 11:46am